Skip to main content
Erschienen in: Journal of Neurology 1/2012

01.01.2012 | Original Communication

Psychiatric symptoms screening in the early stages of Parkinson’s disease

verfasst von: Paulo Bugalho, Joaquim Alves da Silva, Inês Cargaleiro, Madalena Serra, Bernardo Neto

Erschienen in: Journal of Neurology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Psychiatric complaints are common in Parkinson’s disease (PD), and have a significant influence in disease outcome and quality of life. Little attention has been paid to psychiatric symptoms at early stage disease. We aimed to screen a population of early stage PD patients for psychiatric symptoms and to study the relation with motor and cognitive function. Thirty-six early stage PD patients underwent motor [Hoehn and Yahr (HY), Unified Parkinson’s Disease Rating Scale] and cognitive [Frontal Assessment Battery, Mini-Mental State Examination (MMSE)] assessment as well as general psychiatric [Symptom Check-List 90 (SCL-90-R)] and psychosis [Brief Psychiatric Rating Scale (BPRS)] screening. Relation between psychiatric domains scores was studied with principal component analysis. Relation between psychiatric, disease related, cognitive and motor function was assessed with bivariate correlation (Pearson). SCL-90-R scores were higher for somatization (significant scores in 66.7% of patients), depression (36.1%), anxiety (27%) and obsessive—compulsive symptoms (OCS) (52.8%). Scores were highly correlated, except for psychosis and phobia. Depression and anxiety were negatively correlated to MMSE score and dopaminergic doses, respectively. BPRS scores were higher for somatic concern, depression, anxiety and hallucinations. There was segregation between depression, anxiety, hallucinations, other positive psychotic symptoms and negative psychotic symptoms. Depression was related to MMSE score. We found a high prevalence of psychiatric complaints in PD patients, mostly related to depression, anxiety, somatization and OCS. Hallucinations were also frequent, but not associated to cognitive function or dopaminergic doses, suggesting a different physiopathological background.
Literatur
1.
Zurück zum Zitat Aarsland D, Larsen JP, Cummins JL, Laake K (1999) Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 56(5):595–601PubMedCrossRef Aarsland D, Larsen JP, Cummins JL, Laake K (1999) Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 56(5):595–601PubMedCrossRef
2.
Zurück zum Zitat Aarsland D, Larsen JP, Lim NG et al (1999) Range of neuropsychiatric disturbances in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 67(4):492–496PubMedCrossRef Aarsland D, Larsen JP, Lim NG et al (1999) Range of neuropsychiatric disturbances in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 67(4):492–496PubMedCrossRef
3.
Zurück zum Zitat Aarsland D, Brønnick K, Alves G et al (2009) The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson’s disease. J Neurol Neurosurg Psychiatry 80(8):928–930PubMedCrossRef Aarsland D, Brønnick K, Alves G et al (2009) The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson’s disease. J Neurol Neurosurg Psychiatry 80(8):928–930PubMedCrossRef
4.
Zurück zum Zitat Alegret M, Junqué C, Valldeoriola F, Vendrell P, Martí MJ, Tolosa E (2001) Obsessive-compulsive symptoms in Parkinson’s disease. J Neurol Neurosurg Psychiatry 70(3):394–396PubMedCrossRef Alegret M, Junqué C, Valldeoriola F, Vendrell P, Martí MJ, Tolosa E (2001) Obsessive-compulsive symptoms in Parkinson’s disease. J Neurol Neurosurg Psychiatry 70(3):394–396PubMedCrossRef
5.
Zurück zum Zitat American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorder, 4th ed edn. APA, Washington American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorder, 4th ed edn. APA, Washington
6.
Zurück zum Zitat Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24(2):197–211PubMedCrossRef Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24(2):197–211PubMedCrossRef
7.
Zurück zum Zitat Derogatis LR (1977) Symptom check list-90 revised. Administration scoring and procedures manual. Clinical Psychometrics Unit, Johns Hopkins University, Baltimore Derogatis LR (1977) Symptom check list-90 revised. Administration scoring and procedures manual. Clinical Psychometrics Unit, Johns Hopkins University, Baltimore
8.
Zurück zum Zitat Dissanayaka NN, Sellbach A, Matheson S, O’Sullivan JD, Silburn PA, Byrne GJ, Marsh R, Mellick GD (2010) Anxiety disorders in Parkinson’s disease: prevalence and risk factors. Mov Disord 25(7):838–845PubMedCrossRef Dissanayaka NN, Sellbach A, Matheson S, O’Sullivan JD, Silburn PA, Byrne GJ, Marsh R, Mellick GD (2010) Anxiety disorders in Parkinson’s disease: prevalence and risk factors. Mov Disord 25(7):838–845PubMedCrossRef
9.
Zurück zum Zitat Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55:1621–1626PubMed Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55:1621–1626PubMed
10.
Zurück zum Zitat Dubois B, Burn D, Goetz C et al (2007) Diagnostic procedures for Parkinson’s disease dementia: recommendations from the Movement Disorder Society Task Force. Mov Disord 22(16):2314–2324PubMedCrossRef Dubois B, Burn D, Goetz C et al (2007) Diagnostic procedures for Parkinson’s disease dementia: recommendations from the Movement Disorder Society Task Force. Mov Disord 22(16):2314–2324PubMedCrossRef
11.
Zurück zum Zitat Fahn S, Elton RL, and members of the UPDRS Development Committee (1987) Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent Developments in Parkinson’s Disease. Macmollan Health Care Information, Florham Park, pp 153–163, 293–304 Fahn S, Elton RL, and members of the UPDRS Development Committee (1987) Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent Developments in Parkinson’s Disease. Macmollan Health Care Information, Florham Park, pp 153–163, 293–304
12.
Zurück zum Zitat Fénelon G, Mahieux F, Huon R, Ziégler M (2000) Hallucinations in Parkinson’s disease: prevalence, phenomenology and risk factors. Brain 123(Pt 4):733–745PubMedCrossRef Fénelon G, Mahieux F, Huon R, Ziégler M (2000) Hallucinations in Parkinson’s disease: prevalence, phenomenology and risk factors. Brain 123(Pt 4):733–745PubMedCrossRef
13.
Zurück zum Zitat Fernandez HH, Aarsland D, Fénelon G, Friedman JH, Marsh L, Tröster AI et al (2008) Scales to assess psychosis in Parkinson’s disease: critique and recommendations. Mov Disord 23(4):484–500PubMedCrossRef Fernandez HH, Aarsland D, Fénelon G, Friedman JH, Marsh L, Tröster AI et al (2008) Scales to assess psychosis in Parkinson’s disease: critique and recommendations. Mov Disord 23(4):484–500PubMedCrossRef
14.
Zurück zum Zitat Folstein M, Folstein S, McHugh P (1975) Mini-mental state a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRef Folstein M, Folstein S, McHugh P (1975) Mini-mental state a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRef
15.
Zurück zum Zitat Friedman A (1994) Old-onset Parkinson’s disease compared with young-onset disease: clinical differences and similarities. Acta Neurol Scand 89(4):258–261PubMedCrossRef Friedman A (1994) Old-onset Parkinson’s disease compared with young-onset disease: clinical differences and similarities. Acta Neurol Scand 89(4):258–261PubMedCrossRef
16.
Zurück zum Zitat Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson’s disease. Arch Neurol 56:33–39PubMedCrossRef Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson’s disease. Arch Neurol 56:33–39PubMedCrossRef
17.
Zurück zum Zitat Graham JM, Grünewald RA, Sagar HJ (1997) Hallucinosis in idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 63(4):434–440PubMedCrossRef Graham JM, Grünewald RA, Sagar HJ (1997) Hallucinosis in idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 63(4):434–440PubMedCrossRef
18.
Zurück zum Zitat Harbishettar V, Pal PK, Janardhan Reddy YC, Thennarasu K (2005) Is there a relationship between Parkinson’s disease and obsessive-compulsive disorder? Parkinsonism Relat Disord 11(2):85–88PubMedCrossRef Harbishettar V, Pal PK, Janardhan Reddy YC, Thennarasu K (2005) Is there a relationship between Parkinson’s disease and obsessive-compulsive disorder? Parkinsonism Relat Disord 11(2):85–88PubMedCrossRef
19.
Zurück zum Zitat Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442PubMed Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442PubMed
20.
Zurück zum Zitat Jankovic J, McDermott M, Carter J et al (1990) Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. Neurology 40(10):1529–1534PubMed Jankovic J, McDermott M, Carter J et al (1990) Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. Neurology 40(10):1529–1534PubMed
21.
Zurück zum Zitat Kenangil G, Orken DN, Ur E, Forta H (2010) Frontal assessment battery in patients with Parkinson disease in a Turkish population. Cogn Behav Neurol 23(1):26–28PubMedCrossRef Kenangil G, Orken DN, Ur E, Forta H (2010) Frontal assessment battery in patients with Parkinson disease in a Turkish population. Cogn Behav Neurol 23(1):26–28PubMedCrossRef
22.
Zurück zum Zitat Kostić VS, Agosta F, Petrović I et al (2010) Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology 75(10):857–863PubMedCrossRef Kostić VS, Agosta F, Petrović I et al (2010) Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology 75(10):857–863PubMedCrossRef
23.
Zurück zum Zitat Kulisevsky J, Pagonabarraga J, Pascual-Sedano B, García-Sánchez C, Gironell A, Trapecio Group Study (2008) Prevalence and correlates of neuropsychiatric symptoms in Parkinson’s disease without dementia. Mov Disord 23(13):1889–1896PubMedCrossRef Kulisevsky J, Pagonabarraga J, Pascual-Sedano B, García-Sánchez C, Gironell A, Trapecio Group Study (2008) Prevalence and correlates of neuropsychiatric symptoms in Parkinson’s disease without dementia. Mov Disord 23(13):1889–1896PubMedCrossRef
24.
Zurück zum Zitat Maia AF, Pinto AS, Barbosa ER, Menezes PR, Miguel EC (2003) Obsessive compulsive symptoms, obsessive-compulsive disorder, and related disorders in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 15(3):371–374PubMedCrossRef Maia AF, Pinto AS, Barbosa ER, Menezes PR, Miguel EC (2003) Obsessive compulsive symptoms, obsessive-compulsive disorder, and related disorders in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 15(3):371–374PubMedCrossRef
25.
Zurück zum Zitat McGuire PK (1995) The brain in obsessive-compulsive disorder. J Neurol Neurosurg Psychiatry 59:457–459PubMedCrossRef McGuire PK (1995) The brain in obsessive-compulsive disorder. J Neurol Neurosurg Psychiatry 59:457–459PubMedCrossRef
26.
Zurück zum Zitat McKinlay A, Grace RC, Dalrymple-Alford JC, Anderson T, Fink J, Roger D (2008) A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson’s disease patients without dementia. Parkinsonism Relat Disord 14(1):37–42PubMedCrossRef McKinlay A, Grace RC, Dalrymple-Alford JC, Anderson T, Fink J, Roger D (2008) A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson’s disease patients without dementia. Parkinsonism Relat Disord 14(1):37–42PubMedCrossRef
27.
Zurück zum Zitat Nègre-Pagès L, Grandjean H, Lapeyre-Mestre M, Montastruc JL, Fourrier A, Lépine JP, Rascol O, DoPaMiP Study Group (2010) Anxious and depressive symptoms in Parkinson’s disease: the French cross-sectionnal DoPaMiP study. Mov Disord 25(2):157–166PubMedCrossRef Nègre-Pagès L, Grandjean H, Lapeyre-Mestre M, Montastruc JL, Fourrier A, Lépine JP, Rascol O, DoPaMiP Study Group (2010) Anxious and depressive symptoms in Parkinson’s disease: the French cross-sectionnal DoPaMiP study. Mov Disord 25(2):157–166PubMedCrossRef
28.
Zurück zum Zitat Onofrj M, Bonanni L, Manzoli L, Thomas A (2010) Cohort study on somatoform disorders in Parkinson disease and dementia with Lewy bodies. Neurology 74(20):1598–1606PubMedCrossRef Onofrj M, Bonanni L, Manzoli L, Thomas A (2010) Cohort study on somatoform disorders in Parkinson disease and dementia with Lewy bodies. Neurology 74(20):1598–1606PubMedCrossRef
29.
Zurück zum Zitat Overall JE, Gorham DR (1988) The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol Bull 24:97–99 Overall JE, Gorham DR (1988) The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol Bull 24:97–99
30.
Zurück zum Zitat Parkin SG, Gregory RP, Scott R et al (2002) Unilateral and bilateral pallidotomy for idiopathic Parkinson’s disease: a case series of 115. Mov Disord 17:682–692PubMedCrossRef Parkin SG, Gregory RP, Scott R et al (2002) Unilateral and bilateral pallidotomy for idiopathic Parkinson’s disease: a case series of 115. Mov Disord 17:682–692PubMedCrossRef
31.
Zurück zum Zitat Pontone GM, Williams JR, Anderson KE et al (2009) Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson’s disease. Mov Disord 24(9):1333–1338PubMedCrossRef Pontone GM, Williams JR, Anderson KE et al (2009) Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson’s disease. Mov Disord 24(9):1333–1338PubMedCrossRef
32.
Zurück zum Zitat Sanchez-Ramos JR, Ortoll R, Paulson GW (1996) Visual hallucinations associated with Parkinson disease. Arch Neurol 53(12):1265–1268PubMedCrossRef Sanchez-Ramos JR, Ortoll R, Paulson GW (1996) Visual hallucinations associated with Parkinson disease. Arch Neurol 53(12):1265–1268PubMedCrossRef
33.
Zurück zum Zitat Schiffer RB, Kurlan R, Rubin A, Boer S (1988) Evidence for atypical depression in Parkinson’s disease. Am J Psychiatry 145(8):1020–1022PubMed Schiffer RB, Kurlan R, Rubin A, Boer S (1988) Evidence for atypical depression in Parkinson’s disease. Am J Psychiatry 145(8):1020–1022PubMed
34.
Zurück zum Zitat Siri C, Cilia R, De Gaspari D et al (2010) Psychiatric symptoms in Parkinson’s disease assessed with the SCL-90R self-reported questionnaire. Neurol Sci 31(1):35–40PubMedCrossRef Siri C, Cilia R, De Gaspari D et al (2010) Psychiatric symptoms in Parkinson’s disease assessed with the SCL-90R self-reported questionnaire. Neurol Sci 31(1):35–40PubMedCrossRef
35.
Zurück zum Zitat Takagi R, Kajimoto Y, Kamiyoshi S, Miwa H, Kondo T (2002) The frontal assessment battery at bedside (FAB) in patients with Parkinson’s disease. No To Shinkei 54(10):897–902PubMed Takagi R, Kajimoto Y, Kamiyoshi S, Miwa H, Kondo T (2002) The frontal assessment battery at bedside (FAB) in patients with Parkinson’s disease. No To Shinkei 54(10):897–902PubMed
36.
Zurück zum Zitat Tandberg E, Larsen JP, Aarsland D, Cummings JL (1996) The occurrence of depression in Parkinson’s disease. A community-based study. Arch Neurol 53(2):175–179PubMedCrossRef Tandberg E, Larsen JP, Aarsland D, Cummings JL (1996) The occurrence of depression in Parkinson’s disease. A community-based study. Arch Neurol 53(2):175–179PubMedCrossRef
Metadaten
Titel
Psychiatric symptoms screening in the early stages of Parkinson’s disease
verfasst von
Paulo Bugalho
Joaquim Alves da Silva
Inês Cargaleiro
Madalena Serra
Bernardo Neto
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 1/2012
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-011-6140-8

Weitere Artikel der Ausgabe 1/2012

Journal of Neurology 1/2012 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.